D. E. Shaw & Co., Inc.

Position in IMCR — Immunocore Holdings plc

CIK 1009207 New York, NY

Position in IMCR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$12,862,433

+$2,756,425 QoQ

Shares Held

405,116

+20.9% QoQ

Ownership

0.787%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#30

of 136 holders

Holding Since

Sep 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,017,241,180 across 216 Biotechnology names. IMCR ranks #67 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	5,877,959	$626,707,987
2	ALNY	Alnylam Pharmaceuticals, Inc.	1,104,109	$332,369,932
3	EXEL	Exelixis, Inc.	5,551,747	$302,070,554
4	BBIO	BridgeBio Pharma, Inc.	3,633,007	$270,586,360
5	TGTX	Tg Therapeutics, Inc.	3,400,808	$186,840,390
6	HALO	Halozyme Therapeutics, Inc.	2,006,479	$157,047,110
7	AXSM	Axsome Therapeutics, Inc.	604,753	$148,025,391
8	PTCT	Ptc Therapeutics, Inc.	1,548,919	$126,345,322

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,862,433	405,116	+20.9%	Shares	Defined	2026-08-14
2026-03-31	$10,106,008	335,191	+82.2%	Shares	Defined	2026-05-15
2025-12-31	$6,384,557	183,940	+842.6%	Shares	Defined	2026-02-17
2024-06-30	$661,363	19,515	-86.1%	Shares	Defined	2024-08-14
2024-03-31	$9,106,110	140,094	+65.5%	Shares	Defined	2024-05-15
2023-12-31	$5,783,492	84,653	-38.8%	Shares	Defined	2024-02-14
2023-09-30	$7,183,115	138,403	-37.1%	Shares	Defined	2023-11-14
2023-06-30	$13,188,741	219,959	-30.0%	Shares	Defined	2023-08-14
2023-03-31	$15,545,864	314,439	-13.5%	Shares	Defined	2023-05-15
2022-12-31	$20,739,180	363,399	+174.3%	Shares	Defined	2023-02-14
2022-09-30	$6,219,643	132,502	—	Shares	Defined	2022-11-14
No filing history on record for this holder in this stock.